Elizabeth Hlavinka

Mental health benefits have appeared, but more evidence is needed to understand how GLP-1s work in the brain

New research stirs up debate a ceiling to human lifespan growth and how to counteract aging

Flawed definitions of obesity can harm health outcomes, research indicates. The medical community is taking notice

So far, the CDC has confirmed 20 human cases, with more awaiting confirmation Staff Writer

Experts say RFK Jr.'s anti-vaccine ideology isn't driven by true interest in keeping people healthy

For Kelli Coviello, injections of Wegovy didn't just satiate her appetite and help her lose weight. They lowered her blood pressure, improved her mood, and helped her think clearly. Coviello, a principal's assistant at an elementary school in Massachusetts, would typically get home from work, eat something, and go to bed. A month after starting Wegovy, she has the energy to help a friend campaign for local government, prepare her son's dinner, and go on a walk in the evening instead. Although she is already on antianxiety medication, Wegovy (semaglutide) helped alleviate her anxiety and depression like nothing else had. “I feel like me again,” Coviello says. Semaglutide, the same compound that's in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) receptor agonists. These drugs mimic GLP-1 hormones naturally released in the body when eating. Scientists have long known that these hormones prompt the

Echoing findings from previous research, most excess deaths occurred in infants with congenital abnormalities

Almost no research exists on the topic, illuminating gaps and stigma in menstruation research Staff Writer

Many in the field are calling for increased regulations to protect the dignity of those who die alone

"Post-pandemic amnesia" is a real phenomenon but experts say we shouldn't forget how Trump endangered public health